Ашық рұқсат Ашық рұқсат  Рұқсат жабық Рұқсат берілді  Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

№ 7 (2025)

Мұқаба

Бүкіл шығарылым

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Reviews

The impact of abortions on women’s health

Dolgushina N., Ermakova D., Sheshko E.

Аннотация

The objective of the review was to systematize the literature data on the impact of abortions on women’s health. The paper provides the conclusions that abortions have many negative effects; they cause both early and long-term complications, increasing the risks of gynecological and somatic diseases, obstetric and perinatal complications in subsequent pregnancies. Early pregnancy complications include bleeding, uterine perforation, amniotic fluid embolism, thromboembolic, infectious and inflammatory complications. The long-term consequences of abortions refer to gynecological diseases, infertility, obstetric complications in subsequent pregnancies (gestational diabetes, placenta previa, cervical incompetence, premature birth, bleeding, low birth weight), oncological and cardiovascular diseases, and mental health disorders. Measures aimed at preventing abortions and supporting women in their reproductive choices are important steps to protect women’s general and reproductive health, and as a result, improve the demographic situation.

Conclusion: In recent years, a large number of measures have been taken in the Russian Federation to reduce the number of induced abortions. Clinical guidelines and standards have been approved, and interactive educational modules on psychological pre-abortion counseling have been implemented. Speech modules for communicating with women in situations of reproductive choice have also been introduced into the work of medical organizations. Motivational surveys are conducted as part of a program to provide individual recommendations and support measures for women in such situations.

Obstetrics and Gynecology. 2025;(7):5-11
pages 5-11 views

Modern aspects of preconception care and management of pregnant women with endocrine disorders

Rudyakova V., Khripun I., Kuzmenko N.

Аннотация

The objective of this literature review is to summarize and present the latest data in the field of gynecological endocrinology. The application of this information in clinical practice can help to ensure the successful management of pregnant women with endocrine disorders using an interdisciplinary approach.

The review presents the modern principles of preconception care, management of pregnant women and optimal mode of delivery for women with endocrinopathies such as hyperprolactinemia, non-classical form of congenital adrenal cortex dysfunction, hyper- and hypothyroidism. Preconception care of women with these extragenital pathologies should begin long before pregnancy preceded by long-term and stable treatment of endocrine disease. This approach reduces the risk of pregnancy complications. The management of pregnant women with endocrine disorders requires special attention and a coordinated interdisciplinary approach from obstetricians, gynecologists and endocrinologists.

Conclusion: The rate of endocrine infertility is high. However, conception and successful pregnancy can be achieved with proper preconception care and management of pregnant women that should be guided not only by obstetricians and gynecologists, but also endocrinologists and other specialists.

Obstetrics and Gynecology. 2025;(7):12-17
pages 12-17 views

Characteristics of inflammatory bowel diseases and therapeutic approaches in the era of biologics in pregnant women: risks and recommendations

Ibraimov E., Barieva L., Rumyantseva Z., Sulima A., Reznichenko N., Beglitse D., Rumyantseva E., Berberov R., Yuzbashev E.

Аннотация

This review article analyzes the available data on the use of biological therapy in pregnant women with inflammatory bowel diseases (IBD). Special attention is given to the safety and efficacy of biological agents, as well as potential risks and complications.

Objective: To identify possible optimal therapeutic strategies based on current scientific evidence and clinical observations.

Materials and methods: For the study, a thorough search was carried out for both Russian and international scientific publications on the PubMed platform, including articles, reviews, and meta-analyses published up to 2024. The study is based on the current clinical guidelines of the Russian Federation, as well as international guidelines such as ECCO and NICE. Particular attention was paid to modern data and approaches related to the use of biological drugs in pregnant women with IBD.

Results: The treatment of IBD in pregnant women should be based on an integrated approach, including close collaboration of specialists from various fields, namely gastroenterologists, obstetricians-gynecologists, and colorectal surgeons. To date, the most commonly studied biological drugs used by pregnant women are TNF-α inhibitors. These drugs have a good safety profile for both the mother and the fetus. Vedolizumab and ustekinumab have a similar safety profile to anti-TNF drugs. However, their prescription should be discussed with the patient, taking into account the risks associated with discontinuation or continuation of therapy, as well as the possible impact on the course of pregnancy. Janus kinase inhibitors are the least studied biological drugs used during pregnancy. Due to the potential risks and lack of data, their use should be avoided during pregnancy and after childbirth, especially during breastfeeding.

Conclusion: Biologics are a proven and relatively safe method for maintaining remission, which increases the chances of successful pregnancy and minimizes the risk of complications. However, the safety issues for the fetus and the potential long-term consequences of using such medications remain poorly understood. This requires further research and close medical supervision.

Obstetrics and Gynecology. 2025;(7):19-26
pages 19-26 views

Efficacy and safety of doxycycline in pelvic inflammatory disease: a systematic review and meta-analysis

Mezhevitinova E., Kepsha M., Ilyasova N., Zatevalov A.

Аннотация

Objective: To evaluate the clinical and microbiological efficacy, as well as the safety of doxycycline as part of combination therapy in women with pelvic inflammatory disease (PID).

Materials and methods: The systematic review and meta-analysis were conducted in accordance with the PRISMA checklist. The analysis included randomized controlled trials published from 1967 to June 2025 that assessed the efficacy and safety of doxycycline in various treatment regimens for PID in women aged over 18 years. An electronic search was conducted in PubMed, Cochrane Library, Google Scholar, and ClinicalTrials.gov. The risk of bias was assessed using the RoB-2 tool.

Results: The qualitative and quantitative analysis included eight randomized clinical trials with a total of 1,881 patients. The meta-analysis revealed that clinical efficacy of doxycycline was comparable to that of alternative treatment regimens (OR = 1.17; 95% CI [0.91; 1.49]; p = 0.22). However, microbiological efficacy was significantly higher in the doxycycline group (OR = 1.40; 95% CI [1.14; 1.72]; p = 0.002). Adverse events, mainly related to the gastrointestinal tract, were more frequently observed in regimens including doxycycline, presumably due to the use of its hydrochloride form.

Conclusion: Doxycycline, especially in the form of monohydrate, is an effective and rational component of combination therapy for women with PID, as it provides high microbiological eradication rates with acceptable tolerability. Further research with standardized outcome criteria and extended follow-up is required to clarify its role in therapeutic algorithms.

Obstetrics and Gynecology. 2025;(7):27-38
pages 27-38 views

Original Articles

Prediction of fetal growth restriction using machine learning algorithms

Kan N., Leonova A., Tyutyunnik V., Soldatova E., Ryzhova K., Serebryakova A.

Аннотация

Objective: To investigate the significant clinical and anamnestic predictors of fetal growth restriction (FGR) and develop effective predictive models using machine learning methods (MLM).

Materials and methods: This retrospective study included 620 pregnant women who were observed and delivered at the V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia. The study group comprised 300 patients with FGR, while the control group included 320 patients with healthy pregnancies. An analysis of the clinical and anamnestic data was conducted to build MLM models, including logistic regression and random forest.

Results: The logistic regression model identified the following predictors: age over 40 years, height less than 1.60 m, chronic arterial hypertension, smoking, a history of FGR, and threatened miscarriage in the first trimester with the formation of retrochorial hematoma and bleeding. This model predicts the development of FGR with a sensitivity of 73% and specificity of 80% (AUC 0.81). An alternative model constructed using random forest demonstrated an increased sensitivity of 78% and a decreased specificity of 74% (AUC 0.79). Within the random forest framework, the most significant contributors to the accuracy of the prognosis were age over 40 years, height less than 1.60 m, chronic arterial hypertension, a history of surgery resulting in a uterine scar, a history of FGR, and threatened miscarriage in the first trimester with retrochorial hematoma without bleeding.

Conclusion: Both models exhibited high predictive value for screening for FGR. Logistic regression offers interpretability, whereas random forest enhances the accuracy by accounting for nonlinear relationships. Implementing these models in clinical practice will optimize the monitoring of pregnant women at risk.

Obstetrics and Gynecology. 2025;(7):40-46
pages 40-46 views

Changes in placental weight-to-birth weight ratio in cases of fetal congenital heart disease

Yarygina T., Gasanova R., Dzyuba G., Makhukova N., Barinova I., Shchegolev A., Gus A., Shmakov R.

Аннотация

Objective: Analysis of placental weight-to-birth weight ratio in healthy full-term newborns and in babies born with congenital heart disease.

Materials and methods: A comparative analysis of newborns’ weight, placental weight and placental weight-to-birth weight ratio was conducted between the main group, which comprised 100 observations with prenatally diagnosed fetal CHD and the control group, which included 100 healthy newborns.

Results: In the studied groups, there were no statistically significant differences in birth weight: 3412 (409) g (the 65th percentile) weighed newborns with CHD, and 3397 (429) g (the 64th percentile) weighed healthy newborns (p = 0.8). Placental weight was significantly lower in the group with CHD, compared with the control group – 460 (98) g (the 42th percentile) versus 513 (104) g (the 57th percentile) (p = 0.003). Placental weight-to-birth weight ratio was 0.14 (the 25th percentile) versus 0.15 (the 50th percentile) (p < 0.001), as well as there was lower frequency of observations with placental weight-to-birth weight ratio less than the 10th percentile – 31% and 9% (p < 0.001), respectively.

Conclusion: The observations showed that there was a disproportionate reduction in placental weight in relation to the newborn’s weight in the group with fetal CHD compared with the control group of healthy children, that may be a pathogenetic basis for a high incidence of post-hypoxic complications in this cohort of patients.

Obstetrics and Gynecology. 2025;(7):48-57
pages 48-57 views

Analysis of the causes of relaparotomy after cesarean section (multicenter study)

Zharkin N., Miroshnikov A., Kostenko T., Shatilova A., Dvoryansky S., Dmitrieva S., Tskhay V., Raspopin Y., Falkenberg M., Marina M., Artymuk N., Marochko T., Guseva O., Soboleva A., Panova T., Padrul M., Trushkov A.

Аннотация

Objective: To determine the characteristics of surgical strategies and methods for intra- and postoperative hemostasis in patients undergoing relaparotomy following a cesarean section.

Materials and methods: A multicenter cross-sectional descriptive study was conducted to analyze the clinical and anamnestic data along with treatment outcomes of 97 cases of relaparotomy due to bleeding after cesarean section, which occurred in secondary- and tertiary-level maternity hospitals. Data were collected from six regions of the Russian Federation over three years, from January 1, 2022, to December 1, 2024: n = 20, n = 27, n = 14, n = 8, n = 18, and n = 10.

Results: During the analyzed three years (2022–2024), 44,792 cesarean sections were performed in institutions that reported relaparotomies. The need for surgical hemostasis during the initial operation emerged in 19/97 (19.6%) patients. Relaparotomy was performed in 97 patients, accounting for 0.22% of the total number of cesarean sections. Bleeding after cesarean section was most frequently noted at a gestational age of 37.0 (3) weeks. Relaparotomy was performed in 44 cases following planned operations, in 13 cases urgently, and in 40 cases emergently. Early postoperative bleeding (within 6 h), necessitating re-entry into the abdominal cavity, occurred in 69/97 (71.1%) parturient women. During relaparotomy, the uterus was removed as a source of bleeding in 21/97 (21.6%) cases. Ligation of the internal iliac arteries was performed in 19/97 (19.6%) patients, including five during hysterectomy and 14 while conserving the uterus. Three patients underwent repeated relaparotomy due to ongoing intra-abdominal bleeding. The mean total blood loss resulting from the two surgical interventions was 3,319 mL (1,960) ml. Blood transfusions were administered to 62 patients, of whom three received reinfusion in combination with donor erythrocytes. The mean blood transfusion volume was 1,261 (1,483) ml. The mean duration of stay in the intensive care unit was 65 (55) hours. Transfer to another institution was required in 25/97 (25.8%) postpartum women.

Conclusion: Bleeding most often occurred after planned surgery in pregnant women with uterine scars, indicating an insufficient assessment of risk factors and their prevention. Complex compression hemostasis is most frequently used to stop bleeding, which should be mastered by all surgeons performing cesarean sections.

Obstetrics and Gynecology. 2025;(7):58-66
pages 58-66 views

Neonatal complications and characteristics of postnatal development of infants with fetal growth restriction

Leonova A., Kan N., Tyutyunnik V., Serebryakova A., Khachaturyan A., Pekareva N.

Аннотация

Objective: To investigate neonatal complications and characteristics of postnatal development of infants with fetal growth restriction.

Materials and methods: The retrospective study was carried out in two stages at the Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia (Kulakov Center). The first stage included analysis of the clinical and anamnestic data and the features of the course of pregnancy in 620 women (300 women with fetal growth restriction (FGR) in pregnancy and 320 women with normal pregnancy), and analysis of neonatal complications in 620 newborns (300 newborns who had fetal growth restriction, 320 newborns without fetal growth restriction). All newborns (n = 620) underwent neurosonographic examination after birth, followed by analysis of brain structural changes, as well as analysis of somatic, neurological and ophthalmological complications in the neonatal period. The second stage included analysis of postneonatal complications (from day 29 of postnatal development till the age of 1 year) in 207 infants of the total sample (207/620; 33.4%), who underwent follow-up at the Scientific Pediatric Consultative Department of Kulakov Center after discharge. All infants were divided into 2 groups. The main group included infants who had fetal growth restriction (n = 115). The comparison group included infants with normal anthropometric parameters (n = 92).

Results: The study found that the frequency of complications in newborns with fetal growth restriction was significantly increased. In the neonatal period, these infants were significantly more likely to have central nervous system depression (p < 0.001), hypoxic ischemic encephalopathy (p < 0.001), retinopathy of prematurity (p < 0.001), and pulmonary hypertension (p < 0.001). It should be noted that necrotizing enterocolitis (p < 0.001), skin hemorrhagic syndrome (p < 0.001) and disseminated intravascular coagulation (DIC) (p < 0.001) occurred exclusively in the main group. In the postneonatal period, there was delay in physical and psychomotor development in infants with FGR, as well as the frequency of visual impairments increased by 2 times (p < 0.001).

Conclusion: Fetal growth restriction is associated with adverse neonatal and postneonatal outcomes. This highlights the need for prevention and early diagnosis of this pregnancy complication, as well as the comprehensive step-by-step rehabilitation for infants with fetal growth restriction in the postnatal period.

Obstetrics and Gynecology. 2025;(7):67-75
pages 67-75 views

Сlinical characteristics of Syrian women with uterine leiomyoma

Alali O., Khaddam W., Churnosov M.

Аннотация

Objective: To analyze the clinical characteristics, risk factors, and impact on lifestyle of women with uterine leiomyomas (ULs) and compare these findings with a control group of healthy women.

Materials and methods: Conducted from June 2023 to August 2024, the study included 1,000 Syrian women (500 patients with ULs and 500 controls) aged 22–83 from various cities. A questionnaire formed of 65 questions containing information about the clinical characteristics and risk factors for the development of uterine leiomyomas was used. Data was analyzed using Statistical Packages for Software Sciences (SPSS) version 30.

Results: Revealed significant differences between patients and controls in age at first menstruation (p = 0.046), length of the menstrual cycle (p = 0.016), duration of the menstrual bleeding (p = 0.043), age at menopause (p < 0.001), time elapsed since the last birth (p < 0.001), and endometrial ablation (p = 0.039). Regarding the characteristics of the Fibrous nodes, it indicated that submucosal fibroids were in only 6/500 (1.2%) women, while pedunculated was in 22/500 (4.4%) women, subserosal was in 227/500 (45.4%), and intramural was in 228/500 (45.6%).

Conclusion: This study demonstrated which clinical characteristics and risk factors for uterine leiomyomas were statistically significant in Syrian women. This may help determine the best techniques to diagnose and treat them well in order to prevent complications and reduce their impact on health-related quality of life.

Obstetrics and Gynecology. 2025;(7):76-83
pages 76-83 views

The BAIAP2L1 gene variant as a risk factor for the development of genital endometriosis in combination with endometrial hyperplasia

Ponomareva T., Altukhova O., Ponomarenko I., Churnosov M.

Аннотация

Objective: To investigate the association between single nucleotide variants (SNVs) and the occurrence of genital endometriosis combined with endometrial hyperplasia in the Russian population in the following genes: NC_000017.11 (SHBG): g.7618597G>T (rs12150660), NC_000001.11 (PRMT6):g.107003753A>G (rs17496332), NC_000007.14 (BAIAP2L1):g.98364050T>A (rs3779195), NC_000012.12 (SLCO1B1):g.21178615T>C (rs4149056) and NC_000015.10 (NR2F2):g.96165062T>C (rs8023580).

Materials and methods: GWAS-significant single nucleotide variants (SNVs) associated with sex hormone-binding globulin (SHBG) levels were genotyped in 286 patients with genital endometriosis, including 183 patients with both genital endometriosis and endometrial hyperplasia and 103 patients with isolated genital endometriosis (control group). Logistic regression was used to assess the association between GWAS-significant SNVs linked to SHBG levels and the development of genital endometriosis in combination with endometrial hyperplasia. Allelic, additive, recessive, and dominant models were applied using the gPLINK software.

Results: The A allele of the BAIAP2L1 (rs3779195) gene was identified as a risk factor for the development of endometriosis in combination with endometrial hyperplasia (OR = 2.85; 95% CI 1.36–5.97; рperm = 0.006 for the additive model; OR = 1.91; 95% CI 1.15–3.17; рperm = 0.014 for the allelic model; OR = 2.72; 95% CI 1.26–5.88; рperm = 0.012 for the dominant model). The rs3779195 locus is located in the intronic region of the BAIAP2L1 gene, characterizes DNA interaction with the Foxp1 transcription factor, and is in linkage disequilibrium with 20 SNV, four of which (rs6950023, rs6967728, rs77032872, and rs3779196) exhibit significant regulatory potential.

Conclusion: The A allele of BAIAP2L1 (rs3779195) is associated with an increased risk of genital endometriosis in combination with endometrial hyperplasia.

Obstetrics and Gynecology. 2025;(7):84-91
pages 84-91 views

Characteristics of nutritional status in endometriosis and pain syndrome

Alieva P., Smetnik A., Moskvicheva Y., Dumanovskaya M., Tabeeva G., Ermakova E., Fateeva E., Solopova A., Pavlovich S.

Аннотация

Objective: To analyze and evaluate the nutritional status and nutritional components with potential pro-inflammatory and anti-inflammatory effects in the diet of patients with endometriosis, as well as to study the possible relationship between the nutritional status and intensity of pain syndrome.

Materials and methods: The study included 58 patients aged 19 to 44 years with various forms of endometriosis and pain syndrome. The pain syndrome was assessed using the visual analog scale (VAS) and numeric rating scale (NRS). The nutritional status was assessed by frequency analysis using a computer program developed by the Scientific Research Institute of Nutrition of the Russian Academy of Medical Sciences, 2003–2006 (version 1.2.4). Statistical data processing was performed using IBM SPSS Statistics 27.0.

Results: The comparison of the indicators with the recommended dietary allowance (RDA) of substances showed a deficiency in such important micronutrients as magnesium (Mg), calcium (Ca) (in groups with reduced BMI (rBMI) and high BMI (hBMI), iron, as well as vitamins B1, B2 and B3. Insufficient intake of legumes and whole grains was associated with a lower intake of magnesium in the patients of the study groups. Its values were lower than the median RDA (420 mg/day), namely: 190.1 mg in patients with rBMI, p < 0.001 (RDA); 317.2 mg in patients with normal BMI (nBMI), 267.2 mg in patients with hBMI. Calcium intake was significantly decreased in women with rBMI and hBMI (610.8 mg and 798.2 mg, p < 0.05; RDA of calcium is 1000 mg/day). Excessive consumption of processed meat products (sausages) and semi-finished products led to an increase in the consumption of table salt in patients of all three groups, which naturally caused an increase in sodium intake. There were no significant differences in the intensity of pain syndrome among the patients according to NRS and VAS.

Conclusion: The revealed characteristics of the nutritional status of patients with endometriosis demonstrate the potential for the development of novel therapeutic approaches to pain management. Dietary correction can become a component of complex pain therapy in this category of patients and contribute to improving their quality of life.

Obstetrics and Gynecology. 2025;(7):92-102
pages 92-102 views

Immunogenetic mechanisms of recurrent pathological vaginal discharge in women of reproductive age

Uruymagova A., Mezhevitinova E., Donnikov A.

Аннотация

Objective: To identify immunogenetic factors that predispose women of reproductive age to recurrent pathological vaginal discharge.

Materials and methods: This study enrolled 173 women of reproductive age: 59 with episodic pathological vaginal discharge, 74 with recurrent pathological discharge, and 40 healthy women (control group). Genotyping of single nucleotide polymorphisms (SNPs) in immune-regulatory genes (CD14, CTLA4, IFN-γ, IGF-2, IL-10, IL-12β, IL-18, IL-1α, IL-1β, IL-1R, IL-2, IL-4, IL-4R, IL-6, IL-6R, IL-8, TGFβ1, TNF, and MBL2) and genes associated with the neuroendocrine stress response (CRH, CRHR1, and CRHR22) was performed using PCR-based SNP typing. The expression of cytokine (IL-1β, IL-10, IL-18, and TNF-α) and innate immunity receptor (TLR4) mRNAs in vaginal samples was measured by real-time RT-PCR. Statistical analysis included comparisons of allele/genotype frequencies, risk ratio (RR) calculations with 95% confidence intervals, χ2 test, Mann–Whitney test, and multivariate logistic regression (significance at p < 0.05).

Results: Recurrent pathological vaginal discharge was associated with alterations in local immune response. In the group with recurrent inflammatory discharge, there was significantly increased expression of the anti-inflammatory cytokine IL-10 and decreased IL-18 expression compared to episodic cases, indicating an imbalance in immune regulation. Patients with non-inflammatory recurrences exhibit a different immune profile, characterized by elevated levels of the pro-inflammatory cytokines TNF-α and IL-10. Statistically significant associations were identified between genetic variants and disease recurrence. The GG genotype of the IL-10 -1082 G>A polymorphism increased the risk of recurrent pathological discharge of both inflammatory and non-inflammatory origins, whereas the GG genotypes of the TNF-α -238 G>A polymorphism and CRHR1 (rs17689966) polymorphism significantly increased the likelihood of recurrence in cases of non-inflammatory discharge.

Conclusion: Recurrence of pathological vaginal discharge is driven by a combination of local immune imbalance and genetic predisposition. Polymorphisms in immune-related genes (IL-10, TNF, and CRHR1) may serve as molecular genetic markers of recurrence risk, paving the way for personalized prevention and treatment strategies.

Obstetrics and Gynecology. 2025;(7):103-111
pages 103-111 views

Study of inflammatory and angiogenic biomarker levels in various biological fluids in women with extragenital endometriosis

Kudryavtseva Е., Mangileva Y., Polushina L., Maksimova A., Kopenkin М., Zornikov D., Kovalev V.

Аннотация

Objective: To analyze the content of biomarkers of inflammation and angiogenesis in oral and peritoneal fluids in women with a common form of extragenital endometriosis including ovarian lesions.

Materials and methods: This was a comparative observational study. Group 1 (n=88) consisted of women with confirmed extragenital endometriosis including endometrioid ovarian cysts; group 2 (n=30) consisted of healthy women without signs of endometriosis. The samples of oral fluid (OF) were collected from all participants of the study, and samples of peritoneal fluid (PF) were collected from women of group 1. The levels of vascular endothelial growth factor (VEGF), tumor necrosis factor alpha (TNF-α), and interleukins (IL), namely IL-1β, IL-6, IL-8, and IL-10 were studied in biological fluids.

Results: The level of VEGF in OF was significantly higher in the patients of group 1, namely 906.4 (281.9–178) pg/ml compared to the patients of group 2, 241.9 (105.225–324.475) pg/ml, p<0.001. The level of IL-8 was also significantly higher in group 1 compared to group 2, 100.85 (23.333–208.7) pg/ml versus 11.34 (6.549–21.205) pg/ml, respectively, p<0.001. The levels of TNF-α, IL-6, and IL-10 were higher in group 2. The analysis of the correlation between the levels of markers in OF and PF showed no correlation for IL-8, IL-10 and TNF-α and the presence of a very weak, nonlinear relationship for IL-1β, IL-6 and VEGF.

Conclusion: The data obtained suggest the independence of inflammatory and angiogenic biomarker profiles in different biological compartments. The results highlight the potential for future research into OF as a potential bio substrate that could indirectly reflect the characteristics of the systemic inflammatory response in patients with extragenital endometriosis.

Obstetrics and Gynecology. 2025;(7):112-120
pages 112-120 views

Comparison of methods for detecting biofilm syndrome in bacterial vaginosis

Shalepo K., Spasibova E., Krysanova A., Khusnutdinova T., Budilovskaya O., Storozheva K., Tapilskaya N., Savicheva A., Kogan I.

Аннотация

In bacterial vaginosis, Gardnerella vaginalis and Fannyhessea vaginae form highly structured, dense biofilm consortia. Key cells serve as markers of biofilm organization within bacterial communities.

Objective: To compare microbiological methods for detecting biofilm syndrome in bacterial vaginosis.

Materials and methods: Twenty-eight women with complaints of vaginal discharge were examined. Vaginal discharge was used as the clinical material. Microscopy of preparations stained with Gram and methylene blue, as well as fluorescent in situ hybridization (FISH) or the RiGinaM method, were used. The Femoflor test was used for molecular analysis.

Results: The diagnosis of bacterial vaginosis in the Nugent study was established in 89.3% (25/28) of women. The microscopic evaluation of vaginal microbiocenosis using aniline dyes and the RiGinaM method yielded identical results (L:E ratio less than 4:1, with clue cells detected). Clue cells were not identified by any of the methods in only three cases. Among the 25 patients diagnosed with bacterial vaginosis by the Femoflor test, G. vaginalis was detected in all clinical samples, with an average logarithmic value of 7.55, whereas F. vaginae was detected in 22 cases. In three instances of physiological vaginal microbiocenosis, the total bacterial mass was predominantly represented by lactobacilli. G. vaginalis was found among these women, but their total bacterial mass was low (3.6, 4.1, and 6.8 lg), and F. vaginae was detected in only one case (2.1 lg).

Conclusion: Clue cells, as markers of biofilm bacterial vaginosis, can be detected using Gram staining, methylene blue staining, and the RiGinaM method. Microscopic methods using aniline dyes do not differentiate the types of bacteria present in the clue cells, whereas the RiGinaM method requires specific probes to identify microorganisms. The multiplex PCR method in real time can be utilized for the diagnosis of bacterial vaginosis in conjunction with microscopy methods.

Obstetrics and Gynecology. 2025;(7):121-129
pages 121-129 views

Clinical and anatomical features of patients with apical prolapse

Dubinskaya Е., Gasparov A., Matskevich Е.

Аннотация

Objective: To study clinical and anatomical features of patients with apical prolapse (AP).

Materials and methods: 230 medical records of patients with pelvic organ prolapse who underwent examination and treatment from 2019 to 2024 at the University Clinic "I am healthy!" were analyzed. The main patient group consisted of 130 women with apical prolapse, the comparison group included 100 patients with anterior/posterior vaginal wall prolapse without apical prolapse. Evaluation was performed according to the POP-Q classification, using standard questionnaires (POPDI-6, UDI-6) and clinical examination.

Results: Patients with apical prolapse more often reported incomplete bladder emptying and the need to reduce prolapse to ease voiding. In the comparison group, stress urinary incontinence and lower abdominal pressure were more common. In almost half of the patients with apical prolapse, the leading point was Ba (44.6%). In patients without apical prolapse, prolapse of the posterior vaginal wall (point Bp) occurred most often (62%). No significant differences in symptoms were found between the groups, which complicates the early diagnosis of apical prolapse.

Conclusion: When examining the patients with pelvic organ prolapse and collecting their history, it is necessary to take into account the "pitfalls" that complicate objective diagnosis of apical prolapse. It is necessary to improve the technique of physical examination of gynecological patients for early detection of first-level support defects, which will allow timely prescription of adequate treatment with the best long-term results.

Obstetrics and Gynecology. 2025;(7):130-137
pages 130-137 views

Exchange of Experience

Bilateral fixation of the vaginal stump to the uterosacral ligaments using vNOTES and considering S1–S3 nerve roots

Musin I., Berg E., Yaschuk A., Molokanova A., Murtazina G., Popova Е.

Аннотация

Natural orifice transluminal endoscopic surgery (NOTES) is a new approach in various surgical disciplines. In this paper, we present our experience of using vaginal NOTES (vNOTES) for reconstructive surgery for apical prolapse.

Objective: To describe and illustrate transluminal bilateral fixation of the vaginal stump to the uterosacral ligaments using vNOTES.

Materials and methods: The study included 73 women with stage III–IV pelvic organ prolapse, according to the POP-Q classification. Surgical treatment consisted of extirpation of the uterus followed by surgical correction of pelvic organ prolapse using various methods: transluminal endoscopic fixation of the vaginal stump to the uterosacral ligaments using the vNOTES technique (46 patients), McCall culdeplasty (27 patients). The study was conducted in the Department of Obstetrics and Gynecology No. 2, Bashkir State Medical University.

Results: The advantages of vNOTES compared to traditional vaginal surgery include reduced postoperative pain, improved cosmetic effect and reduced risk of intraoperative damage to the internal organs.

Conclusion: The technical result of using this operative technique is the surgical effectiveness of fixing the vaginal stump with suturing the uterosacral ligament at a distance of 45 mm parallel to the ischium. This distance is considered to be safe in terms of the trajectory of S1–S3 nerve roots.

Obstetrics and Gynecology. 2025;(7):138-144
pages 138-144 views

Experience with bovhyaluronidaze azoximer used in the complex treatment of endometriosis: results of the island intra study

Dubrovina S., Vovkochina M., Berlim Y., Aleksandrina A., Bogunova D.

Аннотация

Background: Fibrosis is one of the key mechanisms responsible for developing endometriosis. Therefore, the effectiveness of treating various forms of endometriosis using antifibrotic therapy, such as Longidaza (bovhyaluronidaze azoximer), is of great importance for practice and requires further study.

Objective: To compare the results of the complex therapy with progestogen and Longidaza (3000 IU lyophilizate and 3000 IU suppositories) with progestogen monotherapy in patients with endometriosis and pain syndrome.

Materials and methods: The study included 72 patients aged 35 to 50 diagnosed with endometriosis. The patients were prescribed progestogen monotherapy (the comparison group included 35 women) or the combined therapy with progestogen and Longidaza (3000 IU lyophilizate injected intramuscularly once every 3 days, 10 injections for 30 days) followed by the administration of Longidaza suppositories 3000 IU rectally once every 5 days, a total of 20 suppositories (the main group included 37 women). The severity of pelvic pain was assessed using the VAS scale, and the quality of life was evaluated using the SF-20 questionnaire after 30 and 120 days. The data of the ultrasound examinations were analyzed to determine the frequency of the fan-shaped shadow of the small focal formations indicator.

Results: The treatment was completed by 66 patients, namely by 34 women from the main group and 32 women from the comparison group. On day 30, the incidence of complaints in the combination therapy group was lower that one in the monotherapy group: 18/34 (52.9%) versus 25/32 (78.1%), respectively (p=0.041). The analysis of pain syndrome using the VAS scale in each of the groups showed a significant decrease in pain levels compared to the initial level by the 30th day of therapy (р<0.001). In the combination therapy group, the pain level was more decreased than one in the monotherapy group: -2.5 [-6.0; -1.0] and -1.0 [-4.0; 0.0], respectively (p=0.039). According to the ultrasound results, the proportion of patients with the fan-shaped shadow of the small focal formations decreased from 15/34 (44.1%) to 9/34 (26.5%) (p=0.041) by the 120th day. The decrease was not significant in the monotherapy group, namely from 9/32 (28.1%) to 6/32 (18.8%) (p=0.317).

Conclusion: The results of the study demonstrate the benefits of using progestogen in combination with Longidaza in the treatment of patients with endometriosis.

Obstetrics and Gynecology. 2025;(7):145-152
pages 145-152 views

Guidelines for the Practitioner

Modern pharmacotherapy of polycystic ovary syndrome

Shabatukova Е., Shcherban D., Kudratova Е., Skvortsova A., Zhukova O.

Аннотация

The article analyzes modern pharmacotherapeutic approaches to the treatment of polycystic ovary syndrome (PCOS), which is one of the most common endocrine disorders among reproductive-aged women. The main statistical indicators of PCOS prevalence are given and the clinical manifestations of this disease are described. The application of combined oral contraceptives, antiandrogenic medications, and insulin sensitizers as first-line pharmacotherapeutic correction methods has been examined. The results of clinical studies confirming the effectiveness of these drugs are summarized and the need for further research to optimize therapy regimens is emphasized. The paper investigates the use of antiandrogens such as spironolactone and cyproterone acetate for correcting androgen-dependent manifestations of PCOS. Additionally, new approaches to PCOS therapy using glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors, which have shown effectiveness in lowering glucose levels, are analyzed. The article emphasizes the significance of additional clinical studies to assess the long-term effects of combined therapy and improve treatment results for patients with PCOS. One of the main goals is to improve insulin sensitivity by using drugs like metformin, which helps to normalize metabolic parameters. Special attention is paid to the role of antiandrogens in correcting the symptoms of hyperandrogenism, namely hirsutism and acne; side effects and individual characteristics of patients are considered as well.

Conclusion: It is necessary to use a differentiated approach to treatment which can depend on the PCOS phenotype and the presence of concomitant metabolic disorders.

Obstetrics and Gynecology. 2025;(7):153-160
pages 153-160 views

DNA methylation in cervical intraepithelial neoplasia and cervical cancer

Anisimova M., Shcherbakova L., Panina O.

Аннотация

The primary cause of cervical cancer development is an infection resulting from the persistent presence of oncogenic human papillomavirus (HPV). Choosing the optimal strategy for risk stratification among HPV-positive women can help identify subgroups with a higher probability of disease progression. One of the key areas of research into carcinogenesis mechanisms involves studying epigenetic changes, such as DNA methylation.

The review presents the current data on DNA methylation of high-risk HPV and host cell DNA in cervical intraepithelial neoplasia (CIN) and cervical cancer. The paper focuses on the most studied epigenetic markers, including CADM1, MAL, PAX1, FAM19A4, as well as new genes such as ZNF582, SOX1, and EPB41L3. The review shows their role in the progression of precancerous lesions, their sensitivity and specificity in comparison with conventional screening methods. Particular attention is paid to the potential of integrating epigenetic markers into screening programs, including the practices in the Russian Federation.

Conclusion: DNA methylation is considered to be a promising approach to the early detection of severe CIN and breast cancer that requires further validation. The currently available DNA methylation markers, particularly their combined panels, still need to be optimized by increasing the specificity of sorting but without reducing their high sensitivity. This process requires identification of both individual markers and methylation panels.

Obstetrics and Gynecology. 2025;(7):161-166
pages 161-166 views

Analysis of pharmacological and surgical treatments for endometriosis

Koryagina O., Lebedeva D., Pavlova T., Konosevich D., Iotchenko М.

Аннотация

Endometriosis is a chronic condition characterized by severe pain, infertility, and reduced quality of life. This article presents the analysis of pharmacological and surgical treatments highlighted in systematic reviews and clinical studies. The efficacy of progestins, gonadotropin-releasing hormone (GnRH) agonists and antagonists, aromatase inhibitors, combined oral contraceptives, and other pharmacological agents is reviewed. The potential side effects, mechanisms of action of different drug groups and their effect on endometriotic lesions are discussed.

Particular attention is given to surgery including laparoscopic and laparotomic techniques and its impact on clinical and reproductive outcomes. The article presents the analysis of the advantages and limitations of surgical treatment including such parameters as remission duration and effects on ovarian reserve. The review provides the comparative analysis of treatment methods as well as the data on the recurrence rate, the need for adjuvant therapy and optimal management strategies for the patients with various types of the disease. The role of combination therapy that includes pharmacological treatment before and after surgery in reducing recurrence rate is considered. The article also examines the potential of emerging therapeutic strategies and highlights the need for further research to define optimal treatment regimens. The review demonstrated the importance of an individual approach and the integration of pharmacological and surgical methods for achieving the best therapeutic outcomes.

Conclusion: Pharmacological and surgical treatments for endometriosis have their benefits and limitations. Pharmacological treatment has been shown to be effective in relieving symptoms and reducing the risk of recurrence, but it comes with limitations in the duration of its use and side effects. Surgical treatment remains the standard for patients with advanced stages of the disease and infertility, since it provides significant improvements in reproductive and clinical outcomes. A combined approach, which includes pharmacological therapy before and after surgery, appears to be the most promising strategy.

Obstetrics and Gynecology. 2025;(7):167-174
pages 167-174 views

Myoinositol and D-chiroinositol in the treatment of patients with anovulatory infertility associated with metabolic disorders: debatable issues

Dikke G., Dukhanin A.

Аннотация

To date, a causal relationship between infertility and metabolic status has been established, but its importance for fertility is underestimated.

The objective of the review is to identify evidence of the efficacy and safety of dietary supplements containing myoinositol (MI) and D-chiroinositol (DCI), and their combinations in female infertility caused by metabolic disorders. The review included 57 publications that met the objective of the review. The analysis of experimental and clinical data showed that there is a large number of studies confirming the efficacy of MI and DCI for the treatment of a number of diseases associated with metabolic disorders, including anovulatory infertility in polycystic ovary syndrome (PCOS), obesity, etc. The comparative assessment of MI/DCI and metformin showed that both medications have comparable effectiveness in normalizing carbohydrate metabolism, reducing insulin resistance and lowering body mass index, but MI/DСI is superior to metformin in normalizing androgen status and the frequency of adverse events. The benefit of combined use of MI and DСI for restoring menstrual and reproductive functions has been identified. However, the optimal MI/DСI ratio, doses and clear indications have not yet been established due to the heterogeneity of studies.

Conclusion: Available clinical data suggest that MI, DСI and their combination with other supplements or their use without supplements improve metabolic and hormonal parameters and reproductive outcomes in patients with PCOS and/or obesity. The effect of inositol treatment on different PCOS phenotypes remains an unresolved issue. Further studies are required to improve the management of metabolic processes and restore ovulation. Thus, the optimal MI/DСI ratio and treatment regimens can be determined based on individual approaches depending on the characteristics of the disease.

Obstetrics and Gynecology. 2025;(7):175-186
pages 175-186 views

Clinical Notes

Surgical treatment of a vesico-uterine fistula after cesarean section

Kozachenko А., Shatylko T., Dzhabiev A., Latfullina E.

Аннотация

Relevance: The article discusses the diagnosis and surgical treatment of a complex obstetric complication, namely vesico-uterine fistula after cesarean section (Youssef’s syndrome), with a minimally invasive access and modern medical technologies. Vesico-uterine fistula is usually a complication of surgical delivery or pathological delivery and it accounts for up to 9% of all urogynecological fistulas. The article presents the analysis of modern literature on genitourinary fistulas and a clinical observation of a vesico-uterine fistula in a 38-year-old patient.

Case report: The patient presented with hypomenorrhea and cyclic discharge of urine with blood during menstruation, periodic pain in the lower abdomen. In addition to standard visual diagnostic techniques, such as ultrasound and MRI, an office cystoscopy was performed to diagnose a fistula. The vesico-uterine fistula was sutured using laparoscopic access, with simultaneous metroplasty performed using fibrin glue. The long-term results of the operation were assessed after 4 months; the patient had no problems with urination; the thickness of the myometrium in the metroplasty area was 4 mm.

Conclusion: In order to prevent the development of a vesico-uterine fistula during cesarean section, it is necessary to perform the bladder mobilization. The vesico-uterine fistula should be sutured by a multidisciplinary surgical team with the participation of a urologist.

Obstetrics and Gynecology. 2025;(7):188-192
pages 188-192 views

Articles

pages 193-198 views